Free Trial

Fort Washington Investment Advisors Inc. OH Has $16.43 Million Holdings in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Fort Washington Investment Advisors Inc. OH decreased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 18.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 240,983 shares of the health services provider's stock after selling 55,493 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned approximately 0.43% of Maximus worth $16,433,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of MMS. V Square Quantitative Management LLC grew its stake in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the last quarter. UMB Bank n.a. lifted its holdings in Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the period. GAMMA Investing LLC lifted its holdings in Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after buying an additional 294 shares during the period. IFP Advisors Inc lifted its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares during the period. Finally, Farther Finance Advisors LLC lifted its holdings in Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after buying an additional 428 shares during the period. Institutional investors own 97.21% of the company's stock.

Maximus Trading Down 0.6%

MMS stock traded down $0.39 during midday trading on Monday, hitting $69.41. The stock had a trading volume of 299,769 shares, compared to its average volume of 567,594. The firm has a market cap of $3.91 billion, a P/E ratio of 14.93 and a beta of 0.62. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The business has a fifty day moving average price of $70.53 and a two-hundred day moving average price of $71.12.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Maximus's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.57 earnings per share. On average, sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were issued a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.73%. Maximus's dividend payout ratio is currently 23.86%.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director now owns 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Check Out Our Latest Research Report on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines